Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID P02751 2335 FN1 FN Glioblastoma Phosphorylation N Y101 P02751 2335 FN1 FN Glioblastoma Phosphorylation N Y106 P02751 2335 FN1 FN Brain lower grade glioma N-linked glycosylation N N430 P02751 2335 FN1 FN Hepatocellular carcinoma N-linked glycosylation N N430 P02751 2335 FN1 FN Lung squamous cell carcinoma Glycosylation N N528 P02751 2335 FN1 FN Melanoma Glycosylation N N528 P02751 2335 FN1 FN Thyroid carcinoma Glycosylation N N528 P02751 2335 FN1 FN Lung squamous cell carcinoma N-linked glycosylation N N528 P02751 2335 FN1 FN Melanoma N-linked glycosylation N N528 P02751 2335 FN1 FN Thyroid carcinoma N-linked glycosylation N N528 P02751 2335 FN1 FN Blastoma S-sulfonation N Y876 P02751 2335 FN1 FN Liver cancer S-sulfonation N Y876 P02751 2335 FN1 FN Stomach cancer S-sulfonation N Y876 P02751 2335 FN1 FN Pancreatic adenocarcinoma Phosphorylation N S904 P02751 2335 FN1 FN Pancreatic adenocarcinoma Phosphorylation N S909 P02751 2335 FN1 FN Breast cancer Phosphorylation N T935 P02751 2335 FN1 FN Breast cancer Phosphorylation N Y937 P02751 2335 FN1 FN Glomerulopathy with fibronectin deposits Phosphorylation N S968 P02751 2335 FN1 FN Glomerulopathy with fibronectin deposits Phosphorylation N T972 P02751 2335 FN1 FN Glomerulopathy with fibronectin deposits Acetylation N K976 P02751 2335 FN1 FN Breast cancer Phosphorylation N S1122 P02751 2335 FN1 FN Bladder urothelial carcinoma N-linked glycosylation N N1244 P02751 2335 FN1 FN Colon adenocarcinoma N-linked glycosylation N N1244 P02751 2335 FN1 FN Glomerulopathy with fibronectin deposits Phosphorylation N S1924 P02751 2335 FN1 FN Glomerulopathy with fibronectin deposits Ubiquitination N K1928 P02751 2335 FN1 FN Glomerulopathy with fibronectin deposits Phosphorylation N Y1970 P02751 2335 FN1 FN Glomerulopathy with fibronectin deposits Acetylation N K1971 P02751 2335 FN1 FN Glomerulopathy with fibronectin deposits Phosphorylation N Y1975 P02751 2335 FN1 FN Hepatocellular carcinoma N-linked glycosylation N N2199 P02751 2335 FN1 FN Liver cancer Phosphorylation N T2363 P02751 2335 FN1 FN Colorectal cancer Phosphorylation N S2384 P02751 2335 FN1 FN Hepatocellular carcinoma Phosphorylation N S2440 P02751 2335 FN1 FN Bladder urothelial carcinoma Phosphorylation C S2475 P02751 2335 FN1 FN Transitional cell carcinoma Phosphorylation C S2475 P02751 2335 FN1 FN Breast invasive carcinoma Phosphorylation N S2475 P02751 2335 FN1 FN Colorectal cancer Phosphorylation N S2475 P02751 2335 FN1 FN Rectum adenocarcinoma Phosphorylation N S2475 P02751 2335 FN1 FN Thyroid carcinoma Phosphorylation N S2475 P16615 488 ATP2A2 ATP2B Keratosis follicularis Ubiquitination N K30 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S38 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S38 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K128 P16615 488 ATP2A2 ATP2B Keratosis follicularis Ubiquitination N K128 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S136 P16615 488 ATP2A2 ATP2B Bladder urothelial carcinoma Ubiquitination N K143 P16615 488 ATP2A2 ATP2B Brain lower grade glioma Ubiquitination N K158 P16615 488 ATP2A2 ATP2B Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K158 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K158 P16615 488 ATP2A2 ATP2B Kidney renal clear cell carcinoma Ubiquitination N K158 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Ubiquitination N K158 P16615 488 ATP2A2 ATP2B Brain lower grade glioma Methylation N R164 P16615 488 ATP2A2 ATP2B Keratosis follicularis Methylation N R164 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Methylation N R164 P16615 488 ATP2A2 ATP2B Keratosis follicularis Ubiquitination N K169 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N S178 P16615 488 ATP2A2 ATP2B Pancreatic adenocarcinoma Phosphorylation N S178 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S184 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N S184 P16615 488 ATP2A2 ATP2B Pancreatic adenocarcinoma Phosphorylation N S184 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S186 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K189 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T191 P16615 488 ATP2A2 ATP2B Head and neck squamous cell carcinoma Phosphorylation N T191 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N T191 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Ubiquitination N K205 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S210 P16615 488 ATP2A2 ATP2B Darier disease Acetylation N K218 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T226 P16615 488 ATP2A2 ATP2B Global developmental delay Phosphorylation N T226 P16615 488 ATP2A2 ATP2B Pancreatic adenocarcinoma Phosphorylation N T226 P16615 488 ATP2A2 ATP2B Global developmental delay Phosphorylation N T230 P16615 488 ATP2A2 ATP2B Colon adenocarcinoma Phosphorylation N T242 P16615 488 ATP2A2 ATP2B Colon adenocarcinoma Ubiquitination N K252 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Ubiquitination N K252 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N S261 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Phosphorylation N Y294 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T345 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N T345 P16615 488 ATP2A2 ATP2B Uterine corpus endometrial carcinoma Phosphorylation N T345 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S346 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N S346 P16615 488 ATP2A2 ATP2B Uterine corpus endometrial carcinoma Phosphorylation N S346 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K352 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Ubiquitination N K352 P16615 488 ATP2A2 ATP2B Uterine corpus endometrial carcinoma Ubiquitination N K352 P16615 488 ATP2A2 ATP2B Thyroid carcinoma Ubiquitination N K400 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N Y407 P16615 488 ATP2A2 ATP2B Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K436 P16615 488 ATP2A2 ATP2B Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N T441 P16615 488 ATP2A2 ATP2B Colon adenocarcinoma Ubiquitination N K451 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma SUMOylation N K480 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma Acetylation N K481 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma Ubiquitination N K481 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma Phosphorylation N T484 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N T484 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma Phosphorylation N S488 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N S488 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K492 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma Ubiquitination N K492 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Ubiquitination N K492 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S495 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N Y497 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N Y497 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T499 P16615 488 ATP2A2 ATP2B Urinary bladder cancer Phosphorylation N S531 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S538 P16615 488 ATP2A2 ATP2B Keratosis follicularis Ubiquitination N K541 P16615 488 ATP2A2 ATP2B Keratosis follicularis Ubiquitination N K543 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S546 P16615 488 ATP2A2 ATP2B Keratosis follicularis Methylation N R549 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S553 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S555 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S555 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T557 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N T557 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Phosphorylation N T557 P16615 488 ATP2A2 ATP2B Breast invasive carcinoma SUMOylation N K585 P16615 488 ATP2A2 ATP2B Darier disease SUMOylation N K585 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S608 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Phosphorylation N S608 P16615 488 ATP2A2 ATP2B Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N T624 P16615 488 ATP2A2 ATP2B Colon adenocarcinoma Phosphorylation N T624 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T624 P16615 488 ATP2A2 ATP2B Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K628 P16615 488 ATP2A2 ATP2B Colon adenocarcinoma Ubiquitination N K628 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K628 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N S663 P16615 488 ATP2A2 ATP2B Bladder urothelial carcinoma Ubiquitination N K683 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K683 P16615 488 ATP2A2 ATP2B Keratosis follicularis Ubiquitination N K683 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Ubiquitination N K683 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K685 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S692 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S692 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Phosphorylation N S692 P16615 488 ATP2A2 ATP2B Bladder urothelial carcinoma Ubiquitination N K711 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S740 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T741 P16615 488 ATP2A2 ATP2B Lung squamous cell carcinoma Acetylation N K757 P16615 488 ATP2A2 ATP2B Lung squamous cell carcinoma Ubiquitination N K757 P16615 488 ATP2A2 ATP2B Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S829 P16615 488 ATP2A2 ATP2B Colon adenocarcinoma Phosphorylation N S829 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Phosphorylation N S829 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N Y836 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S973 P61586 387 RHOA ARH12 ARHA RHO12 Breast adenocarcinoma Ubiquitination N K7 P61586 387 RHOA ARH12 ARHA RHO12 Breast invasive carcinoma Ubiquitination N K7 P61586 387 RHOA ARH12 ARHA RHO12 Lymphoid neoplasm diffuse large B-cell lymphoma Ubiquitination N K7 P61586 387 RHOA ARH12 ARHA RHO12 Non-Hodgkin's lymphoma Ubiquitination N K7 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma Ubiquitination N K7 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma Phosphorylation C T19 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma Phosphorylation N T19 P61586 387 RHOA ARH12 ARHA RHO12 Breast invasive carcinoma Phosphorylation N T19 P61586 387 RHOA ARH12 ARHA RHO12 Non-Hodgkin's lymphoma Phosphorylation N T19 P61586 387 RHOA ARH12 ARHA RHO12 Ovarian cancer Phosphorylation N T19 P61586 387 RHOA ARH12 ARHA RHO12 Prostate adenocarcinoma Phosphorylation N T19 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma Phosphorylation N T19 P61586 387 RHOA ARH12 ARHA RHO12 Uterine corpus endometrial carcinoma Phosphorylation N T19 P61586 387 RHOA ARH12 ARHA RHO12 Non-Hodgkin's lymphoma Phosphorylation C S26 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma Phosphorylation N S26 P61586 387 RHOA ARH12 ARHA RHO12 Prostate adenocarcinoma Phosphorylation N S26 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma Phosphorylation N S26 P61586 387 RHOA ARH12 ARHA RHO12 Uterine corpus endometrial carcinoma Phosphorylation N S26 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma SUMOylation N K27 P61586 387 RHOA ARH12 ARHA RHO12 Esophageal carcinoma SUMOylation N K27 P61586 387 RHOA ARH12 ARHA RHO12 Non-Hodgkin's lymphoma SUMOylation N K27 P61586 387 RHOA ARH12 ARHA RHO12 Prostate adenocarcinoma SUMOylation N K27 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma SUMOylation N K27 P61586 387 RHOA ARH12 ARHA RHO12 Uterine corpus endometrial carcinoma SUMOylation N K27 P61586 387 RHOA ARH12 ARHA RHO12 Esophageal cancer Ampylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Hematologic cancer Ampylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Ovarian cancer Ampylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Stomach cancer Ampylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Breast invasive carcinoma O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Esophageal adenocarcinoma O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Esophageal cancer O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Esophageal carcinoma O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Head and neck squamous cell carcinoma O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Hematologic cancer O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Ovarian cancer O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Stomach cancer O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Uterine corpus endometrial carcinoma O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma Phosphorylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Breast invasive carcinoma Phosphorylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Esophageal adenocarcinoma Phosphorylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Esophageal carcinoma Phosphorylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Head and neck squamous cell carcinoma Phosphorylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma Phosphorylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Uterine corpus endometrial carcinoma Phosphorylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Esophageal cancer Phosphorylation N T37 P61586 387 RHOA ARH12 ARHA RHO12 Head and neck cancer Phosphorylation N T37 P61586 387 RHOA ARH12 ARHA RHO12 Melanoma Phosphorylation N T37 P61586 387 RHOA ARH12 ARHA RHO12 Stomach cancer Phosphorylation N T37 P61586 387 RHOA ARH12 ARHA RHO12 Uterine cancer Phosphorylation N T37 P61586 387 RHOA ARH12 ARHA RHO12 Stomach cancer ADP-ribosylation N N41 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma Phosphorylation N Y42 P61586 387 RHOA ARH12 ARHA RHO12 Breast invasive carcinoma Phosphorylation N Y42 P61586 387 RHOA ARH12 ARHA RHO12 Ectodermal dysplasia Phosphorylation N Y42 P61586 387 RHOA ARH12 ARHA RHO12 Esophageal adenocarcinoma Phosphorylation N Y42 P61586 387 RHOA ARH12 ARHA RHO12 Head and neck squamous cell carcinoma Phosphorylation N Y42 P61586 387 RHOA ARH12 ARHA RHO12 Lung adenocarcinoma Phosphorylation N Y42 P61586 387 RHOA ARH12 ARHA RHO12 Lung squamous cell carcinoma Phosphorylation N Y42 P61586 387 RHOA ARH12 ARHA RHO12 Non-Hodgkin's lymphoma Phosphorylation N Y42 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma Phosphorylation N Y42 P61586 387 RHOA ARH12 ARHA RHO12 Uterine corpus endometrial carcinoma Phosphorylation N Y42 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma Phosphorylation C T60 P61586 387 RHOA ARH12 ARHA RHO12 Head and neck squamous cell carcinoma Phosphorylation N T60 P61586 387 RHOA ARH12 ARHA RHO12 Inborn genetic diseases Phosphorylation N T60 P61586 387 RHOA ARH12 ARHA RHO12 Lung adenocarcinoma Phosphorylation N T60 P61586 387 RHOA ARH12 ARHA RHO12 Pancreatic adenocarcinoma Phosphorylation N T60 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma Phosphorylation N T60 P61586 387 RHOA ARH12 ARHA RHO12 Colon adenocarcinoma Phosphorylation C Y66 P61586 387 RHOA ARH12 ARHA RHO12 Ectodermal dysplasia Phosphorylation N Y66 P61586 387 RHOA ARH12 ARHA RHO12 Head and neck squamous cell carcinoma Phosphorylation N Y66 P61586 387 RHOA ARH12 ARHA RHO12 Inborn genetic diseases Phosphorylation N Y66 P61586 387 RHOA ARH12 ARHA RHO12 Lung adenocarcinoma Phosphorylation N Y66 P61586 387 RHOA ARH12 ARHA RHO12 Non-Hodgkin's lymphoma Phosphorylation N Y66 P61586 387 RHOA ARH12 ARHA RHO12 Pancreatic adenocarcinoma Phosphorylation N Y66 P61586 387 RHOA ARH12 ARHA RHO12 Skin cutaneous melanoma Phosphorylation N Y66 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma Phosphorylation N Y66 P61586 387 RHOA ARH12 ARHA RHO12 Uterine corpus endometrial carcinoma Phosphorylation N S88 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma Phosphorylation N T100 P61586 387 RHOA ARH12 ARHA RHO12 Transitional cell carcinoma Phosphorylation N T100 P61586 387 RHOA ARH12 ARHA RHO12 Uterine corpus endometrial carcinoma Phosphorylation N T100 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma Ubiquitination N K104 P61586 387 RHOA ARH12 ARHA RHO12 Transitional cell carcinoma Ubiquitination N K104 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma Ubiquitination N K118 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma Methylation N K119 P61586 387 RHOA ARH12 ARHA RHO12 Lung adenocarcinoma Methylation N R128 P61586 387 RHOA ARH12 ARHA RHO12 Breast invasive carcinoma Ubiquitination N K133 P61586 387 RHOA ARH12 ARHA RHO12 Lung adenocarcinoma Ubiquitination N K133 P61586 387 RHOA ARH12 ARHA RHO12 Breast invasive carcinoma Ubiquitination N K135 P61586 387 RHOA ARH12 ARHA RHO12 Lung adenocarcinoma Ubiquitination N K135 P61586 387 RHOA ARH12 ARHA RHO12 Breast invasive carcinoma Ubiquitination N K140 P61586 387 RHOA ARH12 ARHA RHO12 Head and neck squamous cell carcinoma Ubiquitination N K140 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma Phosphorylation N Y156 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma Phosphorylation N S160 P61586 387 RHOA ARH12 ARHA RHO12 Head and neck squamous cell carcinoma Phosphorylation N S160 P16615 488 ATP2A2 ATP2B Chronic hypoxic pulmonary hypertension lung tissue Serotonylation U 32116663 P02751 2335 FN1 FN Muscular dystrophy myoblast cells Glycosylation P 34012031 P61586 387 RHOA ARH12 ARHA RHO12 Breast cancer tumor tissue Polyubiquitination U 35654587 P16615 488 ATP2A2 ATP2B Pathological cardiac hypertrophy cardiomyocytes Deubiquitination D 36722348 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma tumor tissue Tyrosine phosphorylation U Y990 37719369 P61586 387 RHOA ARH12 ARHA RHO12 Colorectal cancer SW480 and SW1116 cells Serotonylation P Q52 37046308 P61586 387 RHOA ARH12 ARHA RHO12 Colorectal cancer SW480 and SW1116 cells Serotonylation P Q63 37046308 P61586 387 RHOA ARH12 ARHA RHO12 Pulmonary hypertension lung tissue Serotonylation U Q63 19299501 P61586 387 RHOA ARH12 ARHA RHO12 Colorectal cancer SW480 and SW1116 cells Serotonylation P Q136 37046308 P16615 488 ATP2A2 ATP2B Heart failure Acetylation U K492 30786847 P16615 488 ATP2A2 ATP2B Heart failure Deacetylation D K492 30786847 P61586 387 RHOA ARH12 ARHA RHO12 Breast cancer/tumor/carcinoma tumor tissue Phosphorylation U 23324271 P02751 2335 FN1 FN Pulmonary hypertension lung tissue Serotonylation U 22523280 P16615 488 ATP2A2 ATP2B Cardiomyopathy SUMOylation D K480 21900893 P16615 488 ATP2A2 ATP2B Cardiomyopathy SUMOylation D K585 21900893 P61586 387 RHOA ARH12 ARHA RHO12 Gastric cancer Tyrosine phosphorylation U Y42 31056743;33388549